A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

NCT06884085 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypertension

Interventions

DRUG: Co-administration of AD-227A and AD-227B
DRUG: Administration of AD-227

Sponsor

Addpharma Inc.